According to an aide to Sen. Christopher Dodd (D, Connecticut) this morning, the senator has been diagnosed with early stage prostate cancer.
Filed under: Diagnosis, Uncategorized | Tagged: Dodd | 2 Comments »
According to an aide to Sen. Christopher Dodd (D, Connecticut) this morning, the senator has been diagnosed with early stage prostate cancer.
Filed under: Diagnosis, Uncategorized | Tagged: Dodd | 2 Comments »
The American Urological Association Foundation is currently developing a new “National Urology Research Agenda.” Please let us know what YOU think the research priorities should be when it comes to prostate cancer!
Filed under: Uncategorized | Comments Off
Today’s news reports deal with: Physician trust, continuity of care, and prostate cancer Predictive tools in prostate cancer risk and care Outcomes after brachytherapy for patients with T1-2 disease
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: brachytherapy, continuity of care, nomograms, outcomes, predictive tools, trust | 2 Comments »
A recent publication has attempted to determine the impact of mass, population-based screening for prostate cancer in the UK, using PSA testing and subsequent biopsies as appropriate.
Filed under: Diagnosis, Risk, Uncategorized | Tagged: PSA, risk, screening, testing | 1 Comment »
A new study from a group at Duke University has attempted to assess whether data based on PSA doubling times in men with PSA levels up to 0.2 ng/ml can be used as effectively to make early treatment decisions for men with a rising PSA after first-line therapy as can PSA doubling times for men [...]
Filed under: Living with Prostate Cancer, Management | Tagged: early, PSA doubling time, PSADT, radical prostatectomy, salvage | Leave a Comment »
Today’s prostate cancer news reports address such issues as: The quality of prostate cancer care in the US Does PSA have a therapeutic impact on prostate cancer? What patients think about prostate cancer support services New guidelines on pain management for urologists
Filed under: Living with Prostate Cancer, Management | Leave a Comment »
An article just published by a highly respected group of specialists in the Journal of Clinical Oncology adds emphasis to the problem faced by patients newly diagnosed with low- or intermediate-risk localized prostate cancer.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: mortality, nomogram, PCSM, prostate cancer-specific, radical prostatectomy | 7 Comments »
Today’s news reports address: A new nomogram for predicting outcomes after brachytherapy Results of a Phase III trial of combined androgen blockade in Japan
Filed under: Management, Treatment | Tagged: androgen deprivation, brachytherapy, combined, nomogram | Leave a Comment »
Today’s news reports address items on: The burden of prostate cancer in Canada Pelvic lymph node dissection and RALP Data from early trials of sipuleucel-T in advanced prostate cancer Implementation of osteoporosis screening guidelines in prostate cancer patients
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Canada, guidelines, incidence, mortality, osteoporesis, pelvic lymph node dissection, PLND, Provenge, screening, sipuleucel-T | 3 Comments »
A new study provides us with evaluated associations between demographic and clinical characteristics, quality of life outcome measures, and the use of aids to erectile function in men with prostate cancer.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: erectile function, localized disease | 1 Comment »
According to a press release from the Ohio State University Comprehensive Cancer Center, researchers at that center, in collaboration with others at the Dana-Farber Cancer Institute in Boston, believe they have been able to reveal how late-stage, hormone-independent prostate tumors gain the ability to grow without need of hormones.
Filed under: Drugs in development, Living with Prostate Cancer | Tagged: hormone-refractory prostate cancer | Leave a Comment »
The differences in risk for and mortality from prostate cancer across racial and ethnic lines have been well documented.However, there has been continuing controversy over the degree to which socioeconomic status (SES) may be able to account for these differences.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: ethnicity, mortality, race, risk | Leave a Comment »
In today’s news reports we comment on studies dealing with: PSA level, body mass index, risk, and outcomes External beam radiotherapy in treatment of Japanese patients An endorectal balloon to prevent anal/rectal side effects of radiation? The optimal period of neoadjuvant hormone therapy prior to radiation therapy
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: BMI, body mass index, EBRT, endorectal balloon, external beam radiation, neoadjuvant hormone therapy, obesity, PSA | Leave a Comment »
America’s Prostate Cancer Organizations, including Prostate Cancer International, have again taken joint action to bring our voices together to focus on important issues that affect prostate cancer in the ongoing health care reform debate.
Filed under: Uncategorized | Leave a Comment »
Joseph Smith’s editorial on early detection of prostate cancer in the August issue of the Journal of Urology is now available in full, on line. We recommend this to every member of the patient and professional community.
Filed under: Uncategorized | 6 Comments »